Safety and Efficacy of Partial Omentectomy in Laparoscopic Distal Gastrectomy for pT3-T4a Stage Gastric Cancer

被引:2
作者
Song, Min [1 ]
Jiang, Yifan [2 ]
Liu, Yi [2 ]
Li, Zonglin [2 ,3 ]
机构
[1] Southwest Med Univ, Dept Lab Med, Affiliated Hosp, Luzhou, Peoples R China
[2] Southwest Med Univ, Affiliated Hosp, Dept Gen Surg Gastrointestinal Surg, Luzhou, Peoples R China
[3] Southwest Med Univ, Affiliated Hosp, Dept Gen Surg Gastrointestinal Surg, Luzhou 646000, Peoples R China
来源
INTERNATIONAL JOURNAL OF GENERAL MEDICINE | 2023年 / 16卷
关键词
partial omentectomy; total omentectomy; gastric cancer; laparoscopic distal gastrectomy; surgical outcomes; oncological outcomes;
D O I
10.2147/IJGM.S434090
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Partial omentectomy (PO) has been gradually applied in laparoscopic gastrectomy for gastric cancer (GC); however, its efficacy remains unclear. The purpose of this study was to assess the safety and efficacy of PO in laparoscopic distal gastrectomy for pT3-T4a stage GC.Patients and Methods: From June 2019 to May 2021, 108 patients with pT3 or pT4a stage GC who underwent laparoscopic distal gastrectomy were retrospectively included and divided into the PO (n=58) and total omentectomy (TO, n=50) groups. The surgical outcomes, recurrence patterns and postoperative 2-year overall survival (OS) rates were compared between the PO and TO groups.Results: The PO group showed a shorter operation time than the TO group (183.9 +/- 21.6 vs 197.6 +/- 22.7 min, p=0.002). Less intraoperative blood loss (155.3 +/- 113.0 vs 178.8 +/- 154.4 mL, p=0.336) and intraoperative complications (5.1% vs 12.0%, p=0.298) were also observed in the PO group than in the TO group, but the difference was not significant. The numbers of retrieved lymph nodes (LNs) and metastatic LNs, postoperative hospital stays and postoperative complications in the two groups were comparable (p>0.05). Moreover, the postoperative overall recurrence rates (25.9% vs 26.0%, p=0.987) and the 2-year OS rates (63.8% vs 65.4%, p=0.437) in the PO and TO groups were also comparable. TO was not an independent prognostic factor for GC patients (HR=0.806, p=0.443).Conclusion: In laparoscopic distal gastrectomy, PO could provide better surgical outcomes and comparable oncological outcomes compared to TO for patients with pT3-T4a stage GC, suggesting that PO may be an acceptable surgical procedure for these patients.
引用
收藏
页码:4681 / 4690
页数:10
相关论文
共 24 条
  • [1] Hyperthermic intraperitoneal chemotherapy (HIPEC) as adjuvant and therapeutic options for patients with advanced gastric cancer at high risk of recurrence or established peritoneal metastases: a single-centre experience
    Allievi, Niccolo
    Bianco, Federica
    Pisano, Michele
    Montori, Giulia
    Fugazzola, Paola
    Coccolini, Federico
    Lotti, Marco
    Mosconi, Stefania
    Merelli, Barbara
    Campanati, Luca
    Lucianetti, Alessandro
    Ansaloni, Luca
    Magnone, Stefano
    [J]. UPDATES IN SURGERY, 2023, 75 (01) : 159 - 167
  • [2] Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition)
    Baba, Eishi
    Terashima, Masanori
    Fujishiro, Mitsuhiro
    [J]. GASTRIC CANCER, 2023, 26 (01) : 1 - 25
  • [3] Survival benefit of bursectomy in patients with resectable gastric cancer: interim analysis results of a randomized controlled trial
    Fujita, Junya
    Kurokawa, Yukinori
    Sugimoto, Tomoyuki
    Miyashiro, Isao
    Iijima, Shohei
    Kimura, Yutaka
    Takiguchi, Shuji
    Fujiwara, Yoshiyuki
    Mori, Masaki
    Doki, Yuichiro
    [J]. GASTRIC CANCER, 2012, 15 (01) : 42 - 48
  • [4] Omentum-preserving gastrectomy for advanced gastric cancer: a propensity-matched retrospective cohort study
    Hasegawa, Shinichi
    Kunisaki, Chikara
    Ono, Hidetaka
    Oshima, Takashi
    Fujii, Shoichi
    Taguri, Masataka
    Morita, Satoshi
    Sato, Tsutomu
    Yamada, Roppei
    Yukawa, Norio
    Rino, Yasushi
    Masuda, Munetaka
    [J]. GASTRIC CANCER, 2013, 16 (03) : 383 - 388
  • [5] Long-Term Outcomes of Laparoscopic Distal Gastrectomy for Locally Advanced Gastric Cancer: The KLASS-02-RCT Randomized Clinical Trial
    Hyung, Woo Jin
    Yang, Han-Kwang
    Park, Young-Kyu
    Lee, Hyuk-Joon
    An, Ji Yeong
    Kim, Wook
    Kim, Hyoung-Il
    Kim, Hyung-Ho
    Ryu, Seung Wan
    Hur, Hoon
    Kim, Min-Chan
    Kong, Seong-Ho
    Cho, Gyu Seok
    Kim, Jin-Jo
    Park, Do Joong
    Ryu, Keun Won
    Kim, Young Woo
    Kim, Jong Won
    Lee, Joo-Ho
    Han, Sang-Uk
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (28) : 3304 - 3313
  • [6] Japanese gastric cancer treatment guidelines 2018 (5th edition)
    Japanese Gastric Cancer Association
    [J]. GASTRIC CANCER, 2021, 24 (01) : 1 - 21
  • [7] Role of omentectomy as part of radical surgery for gastric cancer
    Jongerius, E. J.
    Boerma, D.
    Seldenrijk, K. A.
    Meijer, S. L.
    Scheepers, J. J. G.
    Smedts, F.
    Lagarde, S. M.
    Ponz, O. Balague
    Henegouwen, M. I. van Berge
    van Sandick, J. W.
    Gisbertz, S. S.
    [J]. BRITISH JOURNAL OF SURGERY, 2016, 103 (11) : 1497 - 1503
  • [8] A comparison of total versus partial omentectomy for advanced gastric cancer in laparoscopic gastrectomy
    Kim, Dong Jin
    Lee, Jun Hyun
    Kim, Wook
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2014, 12
  • [9] Peritoneal Seeding Is More Common in Gastric Cancer Patients with FGFR2 Amplification or High Tumor Mutation Burden
    Kim, Hyunjin
    Park, Sujin
    Kang, So Young
    Ahn, Soomin
    Kim, Kyoung-Mee
    [J]. DIAGNOSTICS, 2022, 12 (10)
  • [10] Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trial
    Kurokawa, Yukinori
    Doki, Yuichiro
    Mizusawa, Junki
    Terashima, Masanori
    Katai, Hitoshi
    Yoshikawa, Takaki
    Kimura, Yutaka
    Takiguchi, Shuji
    Nishida, Yasunori
    Fukushima, Norimasa
    Iwasaki, Yoshiaki
    Kaji, Masahide
    Hirao, Motohiro
    Katayama, Hiroshi
    Sasako, Mitsuru
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (07): : 460 - 468